The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

Author： Vansteenkiste Johan   Wauters Isabelle  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.3, 2005-03, pp. : 429-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darbepoetin Alfa: A Review of its Use in the Treatment of Anaemia in Patients with Cancer Receiving Chemotherapy

By Siddiqui M. Asif A.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 997-1012

Adis International

Access to resources Recommend Favorite

Darbepoetin-alfa: improved efficacy against chemotherapy-induced anaemia?

By  

Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial

By Reed Shelby D.   Radeva Jasmina I.  

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 479-494

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite